In conclusion, MHC Hammer enables accurate estimation of allele-specific HLA disruption, revealing that it is a common feature of NSCLC and ER+ breast cancer that facilitates immune escape and cancer evolution. The gene discussed is HLA-C; the disease is breast carcinoma.